Noninvasive monitoring of basal cell carcinomas treated with systemic hedgehog inhibitors: Pseudocysts as a sign of tumor regression

Journal of the American Academy of Dermatology

Volumn 71, Issue 4, 2014, Pages 725-730

  Maier, Tanja ^a   Kulichova, Daniela ^a   Ruzicka, Thomas ^a   Berking, Carola ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Basal cell carcinoma; Hedgehog inhibitor; High definition optical coherence tomography; Noninvasive diagnosis; Reflectance confocal microscopy.

Indexed keywords

SONIDEGIB; VISMODEGIB; ANILIDE; BIPHENYL DERIVATIVE; PYRIDINE DERIVATIVE; SONIC HEDGEHOG PROTEIN;

ARTICLE; BASAL CELL CARCINOMA; CANCER CHEMOTHERAPY; CANCER REGRESSION; CLINICAL ARTICLE; CONFOCAL LASER SCANNING MICROSCOPE; CONFOCAL MICROSCOPY; HIGH DEFINITION OPTICAL COHERENCE TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PSEUDOCYST; TUMOR REGRESSION; AGED; BIOPSY; CANCER STAGING; COMPARATIVE STUDY; CYST; DRUG ANTAGONISM; DRUG EFFECT; EPIDEMIOLOGY; FEMALE; FOLLOW UP; GERMANY; HEDGEHOG INHIBITOR; HIGH-DEFINITION OPTICAL COHERENCE TOMOGRAPHY; IMMUNOHISTOCHEMISTRY; MALE; METHODOLOGY; MIDDLE AGED; NEEDLE BIOPSY; NONINVASIVE DIAGNOSIS; ORAL DRUG ADMINISTRATION; PATHOLOGY; PHYSIOLOGIC MONITORING; PREDICTIVE VALUE; PROSPECTIVE STUDY; REFLECTANCE CONFOCAL MICROSCOPY; REMISSION; SKIN TUMOR; TREATMENT OUTCOME; TUMOR INVASION; TUMOR VOLUME;

BASAL CELL CARCINOMA; HEDGEHOG INHIBITOR; HIGH-DEFINITION OPTICAL COHERENCE TOMOGRAPHY; NONINVASIVE DIAGNOSIS; REFLECTANCE CONFOCAL MICROSCOPY;

ADMINISTRATION, ORAL; AGED; ANILIDES; BIOPSY; BIOPSY, NEEDLE; BIPHENYL COMPOUNDS; CARCINOMA, BASAL CELL; CYSTS; FEMALE; FOLLOW-UP STUDIES; GERMANY; HEDGEHOG PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; MONITORING, PHYSIOLOGIC; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PYRIDINES; REMISSION INDUCTION; SAMPLING STUDIES; SKIN NEOPLASMS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84910110528     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2014.04.007     Document Type: Article

References (21)

1. Bath-Hextall F, Leonardi-Bee J, Smith C, Meal A, Hubbard R. Trends in incidence of skin basal cell carcinoma. Additional evidence from a UK primary care database study. Int J Cancer 2007;121:2105-8.
2. Flohil SC, de Vries E, Neumann HA, Coebergh JW, Nijsten T. Incidence, prevalence and future trends of primary basal cell carcinoma in the Netherlands. Acta Derm Venereol 2011;91: 24-30.
3. Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, et al. Incidence estimate of nonmelanoma skin cancer in the United States. Arch Dermatol 2006;146:283-7.
4. de Zwaan SE, Haass NK. Genetics of basal cell carcinoma. Australas J Dermatol 2010;51:81-92.
5. Dummer R, Karpova M, Barysch MJ. Basal cell carcinomas: molecular abnormalities and molecularly targeted therapies. Exp Rev Dermatol 2009;4:355-69.
6. Epstein EH. Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer 2008;8:743-54.
7. Sekulic A, Migden MR, Oro AE, Dirix L, Lewis KD, Hainsworth JD, et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med 2012;366:2171-9.
8. Tang T, Tang JY, Li D, Reich M, Callahan CA, Fu L, et al. Targeting superficial or nodular Basal cell carcinoma with topically formulated small molecule inhibitor of smoothened. Clin Cancer Res 2011;17:3378-87.
9. Von Hoff DD, LoRusso PM, Rudin CM, Reddy JC, Yauch RL, Tibes R, et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 2009;361:1164-72.
10. Aszterbaum M, Rothman A, Johnson RL, Fisher M, Xie J, Bonifas JM, et al. Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J Invest Dermatol 1998;110:885-8.
11. Guitera P, Menzies SW, Longo C, Cesinaro AM, Scolyer RA, Pellacani G. In vivo confocal microscopy for diagnosis of melanoma and basal cell carcinoma using a two-step method: analysis of 710 consecutive clinically equivocal cases. J Invest Dermatol 2012;132:2386-94.
12. Maier T, Braun-Falco M, Hinz T, Schmid-Wendtner MH, Ruzicka T, Berking C. Morphology of basal cell carcinoma in high definition optical coherence tomography: en-face and slice imaging mode, and comparison with histology. J Eur Acad Dermatol Venereol 2013;27:e97-104.
13. Maier T, Kulichová D, Ruzicka T, Kunte C, Berking C. Ex vivo high-definition optical coherence tomography of basal cell carcinoma compared to frozen-section histology in micrographic surgery: a pilot study. J Eur Acad Dermatol Venereol 2014;28:80-5.
14. Ulrich M, Roewert-Huber J, Gonzalez S, Rius-Diaz F, Stockfleth E, Kanitakis J. Peritumoral clefting in basal cell carcinoma: correlation of in vivo reflectance confocal microscopy and routine histology. J Cutan Pathol 2011;38:190-5.
15. Hofmann-Wellenhof R, Pellacani G, Malvehy J, Soyer HP, editors. Reflectance confocal microscopy for skin diseases. Berlin: Springer-Verlag; 2012.
16. Swanson PE, Fitzpatrick MM, Ritter JH, Glusac EJ, Wick MR. Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens. J Cutan Pathol 1998;25:153-9.
17. McArthur GA, Demetri GD, van Oosterom A, Heinrich MC, Debiec-Rychter M, Corless CL, et al. Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225. J Clin Oncol 2005;23:866-73.
18. Themstrup L, Banzhaf CA, Mogensen M, Jemec GB. Optical coherence tomography imaging of non-melanoma skin cancer undergoing photodynamic therapy reveals subclinical residual lesions. Photodiagnosis Photodyn Ther 2014;11:7-12.
19. Venturini M, Sala R, Gonzalez S, Calzavara-Pinton PG. Reflectance confocal microscopy allows in vivo real-time noninvasive assessment of the outcome of methyl aminolaevulinate photodynamic therapy of basal cell carcinoma. Br J Dermatol 2013;168:99-105.
20. Longo C, Casari A, Pepe P,Moscarella E, Zalaudek I, Argenziano G, et al. Confocalmicroscopy insights intothe treatment and cellular immune response of basal cell carcinoma to photodynamic therapy. Dermatology 2012;225:264-70.
21. Banzhaf CA, Themstrup L, Ring HC, Mogensen M, Jemec GB. Optical coherence tomography imaging of non-melanoma skin cancer undergoing imiquimod therapy. Skin Res Technol 2014;20:170-6.